Revvity Inc (STU:PKN)
€ 114.55 0.5 (0.44%) Market Cap: 14.29 Bil Enterprise Value: 16.21 Bil PE Ratio: 61.12 PB Ratio: 1.96 GF Score: 78/100

PerkinElmer Inc at Barclays Global Healthcare Conference Transcript

Mar 14, 2023 / 12:00PM GMT
Release Date Price: €111.44 (-0.70%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

Right. I guess we can get started. Good morning, everybody. Welcome to Miami. Thank you for coming, first day, kicking it off here with Dr. Prahlad Singh of PerkinElmer.

Maybe if you just want to start off and give some real high-level takeaways from the quarter, and how the year is progressing for you guys, and then we can start digging in.

Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director

Yes. I mean as we've talked about at the beginning when we did our earnings call, we are excited about the year. We are excited about our strategy. I mean, I'm sure most, if not all of you, saw the announcement and the close of the divestiture of our applied enterprise and services business.

And we've set up the company to be a pure-play life sciences and diagnostics business, which is high growth and high margin. And that was essentially stage 1 of the culmination of the transformation process that we started many years ago. And we've set the company up really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot